Addison Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Buy
2,618
+348
+15% +$356K 0.51% 55
2026
Q1
$2.09M Buy
2,270
+360
+19% +$365K 0.37% 67
2025
Q4
$2.05M Buy
+1,910
New +$1.83M 0.51% 56

Other funds holding LLY

Addison Capital's LLY Position: Q2 2026 in Review

Addison Capital increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $356K and bringing the position to 2,618 shares worth $3.14M. The position accounts for 0.51% of the portfolio, ranked #55.

Addison Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Addison Capital held 2,618 shares of Eli Lilly worth $3.14M as of Q2 2026.
  • Addison Capital bought 348 Eli Lilly shares in Q2 2026, an estimated $356K.
  • Eli Lilly made up 0.51% of Addison Capital's portfolio in Q2 2026, its #55 holding.
  • Addison Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Addison Capital's 13F filing for Q2 2026, filed 4 Aug 2026.